Many health care stocks outperform the market, OCGN is gaining 18%

DIMCO
2021-11-02

On Monday, shares of Ocugen Inc (OCGN) rose 18.07 percent to $13.98 in what was an all-around good trading morning for the stock market. Ocugen Inc. finished $4.79 behind its 52-week high ($18.77), which it hit on February 8th.

What happened to the OCGN?

Investors in Ocugen (OCGN) have had a rocky ride this year, but those who were able to endure the volatility have reaped the benefits. While the stock has nearly doubled in the last month, the year-to-date performance indicates a 664 percent gain.

Ocugen's success has been founded on its seemingly impossible metamorphosis from a company focused on eye illnesses to one chasing the potential given by Covid-19; the biotech owns the US rights to Covaxin, a Covid-19 vaccine candidate developed by Bharat Biotech in India.

Biotech stock’s performance

  • Artelo Biosciencs (ARTL) moved upwards by 55.11% to $1.11.
  • Ocular Therapeutix Inc (OCUL) increased 6.63 percent to $7.08
  • Kodiak Sciences Inc (KOD) rose 7.59 percent to $125.98, outperforming some of its competitors. The trading volume (107.8 million) exceeded the 50-day average volume of 23.3 million.

Please share your opinion:

Which health care stocks could be the belles of the ball in November?

Do you recommend to buy Ocugen’s stock?

What do you think is the reason for the rise in ocugen's stock price?

Do you think Ocugen's COVID-19 vaccine will continue to drive its shares higher this month?

$Histogenics(OCGN)$ $Artelo Biosciences, Inc.(ARTL)$ $Ocular Therapeutix(OCUL)$ $Kodiak Sciences Inc.(KOD)$

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

  • RoyRoberts
    2021-11-02
    RoyRoberts
    I recommend nothing!!! ONLY my opinion!!! Ladies and Gentleman, Remember: 1) The prime minister of India got Covaxin!!! 2) Millions of Indians got Covaxin!! 3) According to Google!! Corona in India went down dramatically!! GOOGLE IT!!! seems that Covaxin works:))) We face in the short term 3 stages: 1) WHO approval. 2) Canada approval. 3) FDA approval. I hold, just HOLD. GOOD LUCK:)
  • VincentHughes
    2021-11-02
    VincentHughes
    FEB 8 LOW 9.13 HIGH 18.77 CLOSED 9.13 VOL 719,489,088 MASSIVE. WHAT'S THE LIKELIHOOD, IF ANY , PPS GOES BEYOND $18MARK? WILL IT HAPPEN BEFORE OR AFTER APPROVAL? JUST S QUESTION NOTHING MORE DO YOUR OWN DD. INVEST AT YOUR OWN RISK. GLTA
  • HenryHoward
    2021-11-02
    HenryHoward
    Ocgn approval is 1000 %guaranteed because loads of countries already approved it and too many countries already put ocgn to approved vaccines list like Australia new Zealand and many others. Ocgn will own the future!!
  • BartonBecky
    2021-11-02
    BartonBecky
    I don't think the popularity of the vaccine will push up its share price. I think on the contrary, as more and more people have been vaccinated, people's demand for it is no longer so urgent, and you can see that people don't even want to wear masks!
  • MariaEvelina
    2021-11-02
    MariaEvelina
    I like VTVT, better. I have been following this company for a long time. Their business scale has been expanding and their price-to-earnings ratio has been maintained at a high level, so how is your price-to-earnings ratio? you can't just analyze it by rising fast, right?😯
  • JudithGrant
    2021-11-02
    JudithGrant
    😁You really found the bright spot, this company is also very far-sighted, at the same time achieved the success of the transformation, I bought it before, I think it will continue to rise, is preparing to increase its holdings.
发表看法
13
1